Skip to content

APOTHEEK STORME: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTHEEK STORME

BE 0881.859.167
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€20,720
2024 · €22,703-€1,983
Equity
€315,898
2024 · €295,179+€20,720
Cash
€121,214
2024 · €103,891+€17,323
Balance sheet total
€544,138
2024 · €540,620+€3,518

Largest movements

2024 to 2025
Assets
  • Cash +€17,323

    up €17,323 (+16.7%), from €103,891 to €121,214

    mainly Net result for the year (+€20,720) and Accrued charges and deferred income (+€17,577)

  • Tangible fixed assets -€5,472

    down €5,472 (-15.9%), from €34,351 to €28,879

    of which Plant, machinery and equipment: -€5,472

Equity and liabilities
  • Trade debts -€29,526

    down €29,526 (-19.9%), from €148,348 to €118,821

  • Profit (loss) carried forward +€20,720

    up €20,720 (+23.5%), from €88,179 to €108,898

  • Accrued charges and deferred income +€17,577

    up €17,577 (+4,155%), from €423 to €18,000

  • Other debts -€12,482

    no longer reported in 2025 (was €12,482)

  • Tax, wage and social debts +€7,229

    up €7,229 (+8.6%), from €84,189 to €91,418

    of which Remuneration and social security: +€14,651

Income statement
  • Gross operating margin +€54,474

    up €54,474 (+17.3%), from €314,214 to €368,689

  • Staff costs +€51,597

    up €51,597 (+18.9%), from €272,978 to €324,575

  • Depreciation +€4,747

    up €4,747 (+177%), from €2,687 to €7,434

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €22,703
Gross operating margin +€54,474
Staff costs -€51,597
Depreciation -€4,747
Other operating charges -€148
Financial income -€495
Financial charges +€1,816
Taxes -€1,287
Result 2025 €20,720
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€19,285
Investment -€1,961
Financing €0
Cash 2024 €103,891
Net result for the year +€20,720
Depreciation +€7,434
Stocks and contracts +€4,103
Receivables within one year +€4,463
Deferred charges and accrued income -€232
Trade debts -€29,526
Tax, wage and social debts +€7,229
Other debts -€12,482
Accrued charges and deferred income +€17,577
Investment in fixed assets (net) -€1,961
Cash 2025 €121,214
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €540,620 €544,138 +€3,518 +0.7%
Fixed assets 21/28 €34,351 €28,879 -€5,472 -15.9%
Tangible fixed assets 22/27 €34,351 €28,879 -€5,472 -15.9%
Plant, machinery and equipment 23 €34,351 €28,879 -€5,472 -15.9%
Other tangible fixed assets 26 €0 - =
Current assets 29/58 €506,269 €515,259 +€8,990 +1.8%
Stocks and contracts in progress 3 €146,921 €142,819 -€4,103 -2.8%
Stocks 30/36 €146,921 €142,819 -€4,103 -2.8%
Amounts receivable within one year 40/41 €246,744 €242,281 -€4,463 -1.8%
Trade receivables 40 €122,188 €139,057 +€16,869 +13.8%
Other amounts receivable 41 €124,556 €103,223 -€21,332 -17.1%
Current investments 50/53 €6,962 €6,962 = 0.0%
Cash at bank and in hand 54/58 €103,891 €121,214 +€17,323 +16.7%
Deferred charges and accrued income 490/1 €1,751 €1,983 +€232 +13.3%
Total equity and liabilities 10/49 €540,620 €544,138 +€3,518 +0.7%
Equity 10/15 €295,179 €315,898 +€20,720 +7.0%
Contributions 10/11 €20,000 €20,000 = 0.0%
Capital 10 €20,000 €20,000 = 0.0%
Issued capital 100 €20,000 €20,000 = 0.0%
Reserves 13 €187,000 €187,000 = 0.0%
Non-distributable reserves 130/1 €2,000 €2,000 = 0.0%
Legal reserve 130 €2,000 €2,000 = 0.0%
Distributable reserves 133 €185,000 €185,000 = 0.0%
Profit (loss) carried forward 14 €88,179 €108,898 +€20,720 +23.5%
Amounts payable 17/49 €245,441 €228,239 -€17,202 -7.0%
Amounts payable within one year 42/48 €245,018 €210,239 -€34,779 -14.2%
Trade debts 44 €148,348 €118,821 -€29,526 -19.9%
Suppliers 440/4 €148,348 €118,821 -€29,526 -19.9%
Taxes, remuneration and social security 45 €84,189 €91,418 +€7,229 +8.6%
Taxes 450/3 €41,813 €34,391 -€7,421 -17.7%
Remuneration and social security 454/9 €42,376 €57,027 +€14,651 +34.6%
Other amounts payable 47/48 €12,482 - -€12,482
Accrued charges and deferred income 492/3 €423 €18,000 +€17,577 +4,155%
Remuneration, social security and pensions 62 €272,978 €324,575 +€51,597 +18.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,687 €7,434 +€4,747 +177%
Other operating charges 640/8 €341 €488 +€148 +43.4%
Gross operating margin 9900 €314,214 €368,689 +€54,474 +17.3%
Operating profit (loss) 9901 €38,209 €36,192 -€2,017 -5.3%
Financial income 75/76B €1,850 €1,356 -€495 -26.7%
Recurring financial income 75 €1,850 €1,356 -€495 -26.7%
Financial charges 65/66B €4,262 €2,447 -€1,816 -42.6%
Recurring financial charges 65 €4,262 €2,447 -€1,816 -42.6%
Profit (loss) for the period before taxes 9903 €35,797 €35,101 -€696 -1.9%
Income taxes 67/77 €13,094 €14,381 +€1,287 +9.8%
Profit (loss) for the period 9904 €22,703 €20,720 -€1,983 -8.7%
Profit (loss) for the period to be appropriated 9905 €22,703 €20,720 -€1,983 -8.7%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.